Received Nov 10, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| UNK | VACCINE NOT SPECIFIED (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | 2NG23 | — |
Dizziness; Shakiness; This non-serious case was reported by a consumer via call center representative and described the occurrence of dizziness in a 51-year-old female patient who received Flu Seasonal TIV Dresden (Fluarix 2025-2026 season) (batch number 2NG23, expiry date JUN-2026) for prophylaxis. On 06-NOV-2025, the patient received Fluarix 2025-2026 season. On 06-NOV-2025, less than a day after receiving Fluarix 2025-2026 season, the patient experienced dizziness (Verbatim: Dizziness) and tremor (Verbatim: Shakiness). The outcome of the dizziness and tremor were not resolved. It was unknown if the reporter considered the dizziness and tremor to be related to Fluarix 2025-2026 season and Fluarix Pre-Filled Syringe Device. It was unknown if the company considered the dizziness and tremor to be related to Fluarix 2025-2026 season and Fluarix Pre-Filled Syringe Device. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 06-NOV-2025 The patient self-reported this case for herself. The patient did not have any other conditions and did not receive any other products.